1ojf
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
{{Theoretical_model}} | {{Theoretical_model}} | ||
| - | + | ||
[[Image:1ojf.png|left|200px]] | [[Image:1ojf.png|left|200px]] | ||
| - | <!-- | ||
| - | The line below this paragraph, containing "STRUCTURE_1ojf", creates the "Structure Box" on the page. | ||
| - | You may change the PDB parameter (which sets the PDB file loaded into the applet) | ||
| - | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | ||
| - | or leave the SCENE parameter empty for the default display. | ||
| - | --> | ||
{{STRUCTURE_1ojf| PDB=1ojf | SCENE= }} | {{STRUCTURE_1ojf| PDB=1ojf | SCENE= }} | ||
===PENTAMERIC SINGLE DOMAIN ANTIBODY 1V5=== | ===PENTAMERIC SINGLE DOMAIN ANTIBODY 1V5=== | ||
| - | |||
| - | <!-- | ||
| - | The line below this paragraph, {{ABSTRACT_PUBMED_14659739}}, adds the Publication Abstract to the page | ||
| - | (as it appears on PubMed at http://www.pubmed.gov), where 14659739 is the PubMed ID number. | ||
| - | --> | ||
{{ABSTRACT_PUBMED_14659739}} | {{ABSTRACT_PUBMED_14659739}} | ||
| - | |||
| - | ==About this Structure== | ||
| - | Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1OJF OCA]. | ||
==Reference== | ==Reference== | ||
| - | <ref group="xtra">PMID: | + | <ref group="xtra">PMID:014659739</ref><references group="xtra"/> |
[[Category: Brisson, J.-R]] | [[Category: Brisson, J.-R]] | ||
[[Category: Khieu, N H]] | [[Category: Khieu, N H]] | ||
[[Category: Mackenzie, R]] | [[Category: Mackenzie, R]] | ||
[[Category: Zhang, J]] | [[Category: Zhang, J]] | ||
| - | |||
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Apr 8 08:54:25 2010'' | ||
Revision as of 09:44, 21 October 2012
 |
PENTAMERIC SINGLE DOMAIN ANTIBODY 1V5
Template:ABSTRACT PUBMED 14659739
Reference
- Zhang J, Tanha J, Hirama T, Khieu NH, To R, Tong-Sevinc H, Stone E, Brisson JR, MacKenzie CR. Pentamerization of single-domain antibodies from phage libraries: a novel strategy for the rapid generation of high-avidity antibody reagents. J Mol Biol. 2004 Jan 2;335(1):49-56. PMID:14659739
